Zepp Health Corp 6-K, filed Nov 5, 2025

Zepp Health Corp (ZEPP)

6-K 2025-11-05 For: 2025-11-05

Added on April 06, 2026

About this 6-K

Zepp Health Corp filed this 6-K on November 5, 2025.

	As of December 31,		As of September 30,
	2024		2025
		US$		US$
Assets
Current assets:
Cash and cash equivalents		91,069		61,722
Restricted cash		19,666		40,834
Accounts receivable, net		62,965		82,767
Amounts due from related parties		2,663		4,426
Inventories, net		56,789		87,676
Short-term investments		997		1,022
Prepaid expenses and other current assets		17,415		33,318
Total current assets		251,564		311,765

Property, plant and equipment, net		6,898		5,834
Intangible asset, net		7,091		13,730
Goodwill		9,581		9,581
Long-term investments		225,910		219,835
Deferred tax assets		17,465		17,695
Amount due from related parties, non-current		2,019		985
Other non-current assets		4,607		4,867
Operating lease right-of-use assets		3,458		2,135
Total assets		528,593		586,427


	As of December 31,		As of September 30,
	2024		2025
		US$		US$
Liabilities
Current liabilities:
Accounts payable		51,077		105,070
Advance from customers		197		278
Amount due to related parties		2,477		1,733
Accrued expenses and other current liabilities		37,576		38,923
Income tax payables		508		443
Notes payable		61,679		100,048
Short-term bank borrowings		41,853		39,434
Total current liabilities		195,367		285,929
Deferred tax liabilities		3,117		3,171
Long-term borrowings		75,241		69,515
Other non-current liabilities		133		171
Non-current operating lease liabilities		2,007		1,301
Total liabilities		275,865		360,087


	For the Three Months Ended September 30,
	2024			2025
	US$			US$
Revenues		42,462			75,789
Cost of revenues		(25,218	)		(46,866	)
Gross profit		17,244			28,923
Operating expenses:
Selling and marketing		(11,896	)		(12,009	)
General and administrative		(7,026	)		(6,996	)
Research and development		(10,859	)		(10,802	)
Total operating expenses		(29,781	)		(29,807	)
Operating loss		(12,537	)		(884	)

Other income and expenses:
Interest income		941			328
Interest expense		(1,289	)		(1,478	)
Other (expense)/income, net		(84	)		318
Investment loss		-			(100	)
Gain from fair value change of long-term investments		175			556
Loss before income tax and loss from equity method investments		(12,794	)		(1,260	)
Income tax expenses		-			(117	)
Loss before loss from equity method investments		(12,794	)		(1,377	)
Net loss from equity method investments		(465	)		(239	)
Net loss		(13,259	)		(1,616	)
Less: Net loss attributable to noncontrolling interest		(8	)		-
Net loss attributable to Zepp Health Corporation		(13,251	)		(1,616	)

Basic and diluted net loss per share attributable to Zepp Health Corporation		(0.05	)		(0.01	)

Basic and diluted net loss per ADS (16 ordinary shares equal to 1 ADS)		(0.82	)		(0.10	)

Weighted average number of shares used in computing basic and diluted net loss per share		258,386,436			253,097,491

	For the Nine Months Ended September 30,
	2024			2025
	US$			US$
Revenues		123,061			173,732
Cost of revenues		(74,756	)		(108,957	)
Gross profit		48,305			64,775
Operating expenses:
Selling and marketing		(33,220	)		(37,900	)
General and administrative		(18,299	)		(17,898	)
Research and development		(35,098	)		(34,336	)
Total operating expenses		(86,617	)		(90,134	)
Operating loss		(38,312	)		(25,359	)

Other income and expenses:
Interest income		2,901			1,204
Interest expense		(4,105	)		(4,081	)
Other income, net		111			378
Investment loss		-			(100	)
Gain from fair value change of long-term investments		1,978			434
Loss before income tax and loss from equity method investments		(37,427	)		(27,524	)
Income tax expenses		(119	)		(469	)
Loss before loss from equity method investments		(37,546	)		(27,993	)
Net loss from equity method investments		(1,361	)		(1,104	)
Net loss		(38,907	)		(29,097	)
Less: Net loss attributable to noncontrolling interest		(50	)		-
Net loss attributable to Zepp Health Corporation		(38,857	)		(29,097	)

Basic and diluted net loss per share attributable to Zepp Health Corporation		(0.15	)		(0.11	)

Basic and diluted net loss per ADS (16 ordinary shares equal to 1 ADS)		(2.40	)		(1.83	)

Weighted average number of shares used in computing basic and diluted net loss per share		259,433,512			254,405,624

	As of December 31,			As of September 30,
	2024			2025
		US$			US$
Equity
Ordinary shares		26			26
Additional paid-in capital		278,116			281,334
Treasury stock		(14,993	)		(16,072	)
Accumulated retained earnings/(loss)		28,618			(479	)
Accumulated other comprehensive loss		(40,178	)		(38,469	)
Total Zepp Health Corporation shareholders’ equity		251,589			226,340
Noncontrolling interest		1,139			-
Total equity		252,728			226,340
Total liabilities and equity		528,593			586,427